SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001021432-13-000265
Filing Date
2013-10-01
Accepted
2013-10-01 17:17:53
Documents
1
Period of Report
2013-09-30
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8k081313solis.txt 8-K 6033
  Complete submission text file 0001021432-13-000265.txt   7378
Mailing Address 7380 SAND LAKE ROAD SUITE 500 ORLANDO FL 32819
Business Address 7380 SAND LAKE ROAD SUITE 500 ORLANDO FL 32819 202-415-3563
Solis Pharma US, Inc. (Filer) CIK: 0001559060 (see all company filings)

IRS No.: 461873961 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54832 | Film No.: 131127683
SIC: 6770 Blank Checks